The Ohio State University Medical Center is working to shift health care from its current reactive mode to one that is predictive, preventive, personalized and participatory. We call it P4 Medicine.
Tests that identify genetic abnormalities and molecular biomarkers for disease will give patients a clearer picture of their health risks and predict the effect- iveness of preventive and treatment strategies at the molecular level.
Identifying the underlying causes of diseases will lead to treatments that block or slow their progression. Preventive therapies will be customized to each patient, and thus will, be more effective and have fewer side effects.
Each individual's genetic information and behavioral and environmental health data will be used to create a personalized health management plan, customized disease-prevention strategies and, when required, unique disease treatments and therapies.
Patients' lifetime healthcare journeys will be more satisfying, effective, coordinated and convenient because they will be empowered with the information and tools they need to take a more active role in their health. They will work closely with their healthcare providers to plan, manage and achieve their health objectives.